Roche said on Friday that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to its COVID-19 at-home rapid test that can be used by people as young as 14.
The test, which uses a anterior nasal swab sample, is "able to produce accurate, reliable and quick results in as few as 20 minutes" for SARS-CoV-2 and all variants of concern, including Omicron, the drugmaker said in a statement.
The variant has become dominant in the United States with lightning speed, dashing hopes for a more normal holiday season, resurrecting restrictions and stretching the country's testing infrastructure ahead of holiday travel and gatherings."Roche has the capacity to produce tens of millions of tests per month to help support the pandemic response," the Swiss firm said, adding that the test will be available across the U.S. from January.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
CityMD temporarily closes 19 locations amid surge in COVID-19 casesUrgent care chain CityMD announced it is temporarily closing more than a dozen of its 150 locations in New York and New Jersey amid a surge in COVID-19 cases and increased demands for testing.
Lire la suite »
FDA authorizes second antiviral pill to treat Covid-19The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 'for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.'
Lire la suite »
U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillThe U.S. Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar treatment from Pfizer Inc for high-risk patients above the age of 12.
Lire la suite »
FDA OKs Emergency Use of Merck Pill for COVID-19The FDA has granted emergency use authorization to Merck’s antiviral drug to treat adults with mild to moderate COVID-19 who are at risk for severe disease.
Lire la suite »
How to Use a COVID-19 Rapid Test at HomeWebMD's Chief Medical Officer, John Whyte, MD, MPH, demonstrates how to use a COVID-19 rapid antigen test at home.
Lire la suite »
Young People Reduced Cannabis Use Amid Covid-19 Pandemic, Survey ShowsYoung people significantly reduced the use of drugs in 2021. But the COVID-19 pandemic led to the rise in the use of nicotine products and the misuse of prescription medications.
Lire la suite »